Fact CheckerSign in

NCT03541226Completed

Clinical Monitoring, MRI and Neuro-Ophthalmology of a Cohort of Patients With a Clinically Isolated Syndrome (CIS)

Clinical Monitoring, MRI and Neuro-Ophthalmology of a Cohort of Patients With a Clinically Isolated Syndrome

Source: ClinicalTrials.gov · Last updated 3 Dec 2025

Brief summary (registry, in English)

The purpose of this study is to develop tools to detect, measure, monitor and predict axonal damage in the course of CIS and during Multiple sclerosis (MS), in order to be able to consider as early as possible an adaptation of the background treatment in patients with MS. patients with radiological criteria of poor long-term clinical course.

Status (registry)
Completed
Study type
Observational
Enrollment
134 (actual)
First submitted
17 May 2018
Start date
Sept 2014
Primary completion date
Jan 2024
Lead sponsor
University Hospital, Lille
NCT number
NCT03541226

What you commit to

  • Study type: Observational
  • Participants enrolled: 134
  • From Sept 2014 to the primary completion date, Jan 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Atypical CIS for a first relapse of multiple sclerosis (extensive myelitis, bilateral retrobulbar optic neuritis immediately)
  • CIS dating more than 4 months (+/- 15 days)
  • Corticotherapy in the last 4 weeks

Who the study is looking for

  • Any patient who has had a CIS of less than 4 months (+/- 15 days), with at least 1 inflammatory lesion on his initial brain MRI or with normal brain MRI associated with the presence of oligoclonal bands in the CSF,

Age in the registry: 18 years to 50 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Hôpital Roger Salengro (CHRU de Lille)
Coordinator of this site? Confirm its status
LilleFranceUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.